DE60014343D1 - N-(2-phenyl-4-amino-butyl)-1-naphthamide als neurokinin-1 rezeptorantagonisten - Google Patents
N-(2-phenyl-4-amino-butyl)-1-naphthamide als neurokinin-1 rezeptorantagonistenInfo
- Publication number
- DE60014343D1 DE60014343D1 DE60014343T DE60014343T DE60014343D1 DE 60014343 D1 DE60014343 D1 DE 60014343D1 DE 60014343 T DE60014343 T DE 60014343T DE 60014343 T DE60014343 T DE 60014343T DE 60014343 D1 DE60014343 D1 DE 60014343D1
- Authority
- DE
- Germany
- Prior art keywords
- naphthamide
- neurokinin
- phenyl
- butyl
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- VFTQJCVZNTYOKM-UHFFFAOYSA-N n-(4-amino-2-phenylbutyl)naphthalene-1-carboxamide Chemical compound C=1C=CC2=CC=CC=C2C=1C(=O)NCC(CCN)C1=CC=CC=C1 VFTQJCVZNTYOKM-UHFFFAOYSA-N 0.000 title 1
- 239000002742 neurokinin 1 receptor antagonist Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/57—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychology (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9907571 | 1999-04-06 | ||
GBGB9907571.5A GB9907571D0 (en) | 1999-04-06 | 1999-04-06 | Compounds |
PCT/GB2000/001252 WO2000059873A1 (en) | 1999-04-06 | 2000-04-03 | N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60014343D1 true DE60014343D1 (de) | 2004-11-04 |
DE60014343T2 DE60014343T2 (de) | 2006-03-02 |
Family
ID=10850835
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60014343T Expired - Fee Related DE60014343T2 (de) | 1999-04-06 | 2000-04-03 | N-(2-phenyl-4-amino-butyl)-1-naphthamide als neurokinin-1 rezeptorantagonisten |
Country Status (25)
Country | Link |
---|---|
US (3) | US6476077B1 (de) |
EP (1) | EP1169302B1 (de) |
JP (1) | JP2002541137A (de) |
KR (1) | KR20010102580A (de) |
CN (2) | CN1534017A (de) |
AT (1) | ATE277893T1 (de) |
AU (1) | AU3569200A (de) |
BG (1) | BG106074A (de) |
BR (1) | BR0009582A (de) |
CA (1) | CA2368240A1 (de) |
CZ (1) | CZ20013574A3 (de) |
DE (1) | DE60014343T2 (de) |
EE (1) | EE200100520A (de) |
GB (1) | GB9907571D0 (de) |
HK (1) | HK1044145A1 (de) |
HU (1) | HUP0200707A3 (de) |
IL (1) | IL145645A0 (de) |
IS (1) | IS6087A (de) |
NO (1) | NO20014855L (de) |
PL (1) | PL350568A1 (de) |
SK (1) | SK13012001A3 (de) |
TR (1) | TR200102875T2 (de) |
UA (1) | UA67839C2 (de) |
WO (1) | WO2000059873A1 (de) |
ZA (1) | ZA200108176B (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9907571D0 (en) | 1999-04-06 | 1999-05-26 | Zeneca Ltd | Compounds |
GB0019008D0 (en) * | 2000-08-04 | 2000-09-27 | Astrazeneca Ab | Therapeutic compounds |
SE0201938D0 (sv) * | 2002-06-20 | 2002-06-20 | Astrazeneca Ab | New process |
EP1560769B1 (de) * | 2002-11-05 | 2008-02-27 | AstraZeneca AB | Verriegelungsanordnung für einen verschluss auf einen behälter und entsprechender behälter |
JP2006512363A (ja) * | 2002-12-20 | 2006-04-13 | アストラゼネカ・アクチエボラーグ | ピペリジンアミン化合物およびその使用 |
CN101065014A (zh) * | 2004-09-23 | 2007-10-31 | 亚历山大·米哈洛 | 通过诱导逆适应调节神经递质系统的方法 |
US20080045610A1 (en) * | 2004-09-23 | 2008-02-21 | Alexander Michalow | Methods for regulating neurotransmitter systems by inducing counteradaptations |
US9782397B2 (en) | 2011-07-04 | 2017-10-10 | Irbm Science Park S.P.A. | Treatment of corneal neovascularization |
PL3297631T3 (pl) | 2015-05-18 | 2020-03-31 | Nerre Therapeutics Limited | Antagoniści receptora NK-1/NK-3 do leczenia uderzeń gorąca |
CN111918647A (zh) | 2018-02-26 | 2020-11-10 | 圣拉斐尔医院有限公司 | 用于治疗眼痛的nk-1拮抗剂 |
PL3765024T3 (pl) | 2018-03-14 | 2024-08-05 | KaNDy Therapeutics Limited | <div>Nowa formulacja farmaceutyczna zawierająca podwójnych antagonistów receptora nk-1/nk-3</div> |
RU2697414C1 (ru) | 2018-05-11 | 2019-08-14 | Общество с ограниченной ответственностью "АЙ БИ ДИ Терапевтикс" | Новый антагонист тахикининовых рецепторов и его применение |
EP4117673A1 (de) | 2020-03-11 | 2023-01-18 | Ospedale San Raffaele S.r.l. | Behandlung von stammzellenmangel |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI97540C (fi) * | 1989-11-06 | 1997-01-10 | Sanofi Sa | Menetelmä terapeuttisesti käyttökelpoisten, aromaattisesti substituoitujen piperidiini- ja piperatsiinijohdannaisten valmistamiseksi |
JPH08511522A (ja) | 1993-06-07 | 1996-12-03 | メルク エンド カンパニー インコーポレーテッド | ニューロキニンアンタゴニストとしてのスピロ置換アザ環 |
CA2195972A1 (en) * | 1994-08-15 | 1996-02-22 | Merck Sharp & Dohme Limited | Morpholine derivatives and their use as therapeutic agents |
WO1998025617A1 (en) | 1996-12-13 | 1998-06-18 | Merck & Co., Inc. | Substituted aryl piperazines as modulators of chemokine receptor activity |
GB9907571D0 (en) * | 1999-04-06 | 1999-05-26 | Zeneca Ltd | Compounds |
EP1370520A1 (de) * | 2001-03-21 | 2003-12-17 | Pharmacopeia, Inc. | Aryle- sowie biaryle-verbindungen mit mch-modulatorischer wirkung |
-
1999
- 1999-04-06 GB GBGB9907571.5A patent/GB9907571D0/en not_active Ceased
-
2000
- 2000-03-04 UA UA2001117535A patent/UA67839C2/uk unknown
- 2000-04-03 EP EP00914298A patent/EP1169302B1/de not_active Expired - Lifetime
- 2000-04-03 JP JP2000609386A patent/JP2002541137A/ja active Pending
- 2000-04-03 HU HU0200707A patent/HUP0200707A3/hu unknown
- 2000-04-03 DE DE60014343T patent/DE60014343T2/de not_active Expired - Fee Related
- 2000-04-03 AT AT00914298T patent/ATE277893T1/de not_active IP Right Cessation
- 2000-04-03 CZ CZ20013574A patent/CZ20013574A3/cs unknown
- 2000-04-03 TR TR2001/02875T patent/TR200102875T2/xx unknown
- 2000-04-03 IL IL14564500A patent/IL145645A0/xx unknown
- 2000-04-03 KR KR1020017012692A patent/KR20010102580A/ko not_active Application Discontinuation
- 2000-04-03 SK SK1301-2001A patent/SK13012001A3/sk unknown
- 2000-04-03 CN CNA2004100053467A patent/CN1534017A/zh active Pending
- 2000-04-03 EE EEP200100520A patent/EE200100520A/xx unknown
- 2000-04-03 CA CA002368240A patent/CA2368240A1/en not_active Abandoned
- 2000-04-03 WO PCT/GB2000/001252 patent/WO2000059873A1/en not_active Application Discontinuation
- 2000-04-03 CN CN00805623A patent/CN1345307A/zh active Pending
- 2000-04-03 BR BR0009582-6A patent/BR0009582A/pt not_active IP Right Cessation
- 2000-04-03 US US09/937,981 patent/US6476077B1/en not_active Expired - Fee Related
- 2000-04-03 PL PL00350568A patent/PL350568A1/xx unknown
- 2000-04-03 AU AU35692/00A patent/AU3569200A/en not_active Abandoned
-
2001
- 2001-09-26 IS IS6087A patent/IS6087A/is unknown
- 2001-10-04 ZA ZA200108176A patent/ZA200108176B/en unknown
- 2001-10-05 NO NO20014855A patent/NO20014855L/no not_active Application Discontinuation
- 2001-11-01 BG BG106074A patent/BG106074A/xx unknown
-
2002
- 2002-06-26 HK HK02104758.2A patent/HK1044145A1/zh unknown
- 2002-11-01 US US10/286,624 patent/US6586432B2/en not_active Expired - Fee Related
-
2003
- 2003-06-30 US US10/611,052 patent/US6821973B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20030092713A1 (en) | 2003-05-15 |
SK13012001A3 (sk) | 2002-04-04 |
ATE277893T1 (de) | 2004-10-15 |
NO20014855L (no) | 2001-12-06 |
IS6087A (is) | 2001-09-26 |
US6586432B2 (en) | 2003-07-01 |
BG106074A (en) | 2002-05-31 |
UA67839C2 (uk) | 2004-07-15 |
EP1169302A1 (de) | 2002-01-09 |
US6476077B1 (en) | 2002-11-05 |
EE200100520A (et) | 2002-12-16 |
HUP0200707A3 (en) | 2002-11-28 |
PL350568A1 (en) | 2002-12-16 |
HK1044145A1 (zh) | 2002-10-11 |
GB9907571D0 (en) | 1999-05-26 |
CN1534017A (zh) | 2004-10-06 |
NO20014855D0 (no) | 2001-10-05 |
US6821973B2 (en) | 2004-11-23 |
TR200102875T2 (tr) | 2002-01-21 |
US20040106610A1 (en) | 2004-06-03 |
WO2000059873A1 (en) | 2000-10-12 |
AU3569200A (en) | 2000-10-23 |
HUP0200707A2 (en) | 2002-06-29 |
IL145645A0 (en) | 2002-06-30 |
KR20010102580A (ko) | 2001-11-15 |
BR0009582A (pt) | 2001-12-26 |
EP1169302B1 (de) | 2004-09-29 |
DE60014343T2 (de) | 2006-03-02 |
CA2368240A1 (en) | 2000-10-12 |
CN1345307A (zh) | 2002-04-17 |
ZA200108176B (en) | 2003-01-06 |
CZ20013574A3 (cs) | 2002-05-15 |
JP2002541137A (ja) | 2002-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60030741D1 (de) | Chinazoline verbindungen als heilmittel | |
ECSP055701A (es) | Nuevos derivados de pirimidinamida y el uso de los mismos | |
EA200200571A1 (ru) | Новая композиция и ее применение | |
EA200500146A1 (ru) | Моноэтансульфонат 3-z-[1-4-(n-((4-метилпиперазин-1-ил)метилкарбонил)-n-метиламино)анилино)-1-фенилметилен]-6-метоксикарбонил-2-индолинона и его применение в составе фармацевтической композиции | |
BG66085B1 (bg) | Фенилаланинови производни | |
CY1110243T1 (el) | Ανταγωνιστες npyy5 | |
EA200300527A1 (ru) | Новые способы лечения синдрома "усталых ног" | |
DE60014343D1 (de) | N-(2-phenyl-4-amino-butyl)-1-naphthamide als neurokinin-1 rezeptorantagonisten | |
EA200400467A1 (ru) | Производные 3-азабицикло (3.1.0) гексана в качестве антагонистов опиоидного рецептора | |
NO20020282D0 (no) | Nytt difenylpiperidinderivat | |
SE9901077D0 (sv) | Novel use | |
EA200400280A1 (ru) | Новые неочищенные и кристаллические формы гидрохлорида лерканидипина | |
ATE369348T1 (de) | Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie | |
DE60134735D1 (de) | Neue neurokinin-antagonisten zum gebrauch als arzneimittel | |
HUP0003836A2 (hu) | Lazofoxifent tartalmazó gyógyszerkészítmények | |
ATE253359T1 (de) | Antithrombotische mittel | |
EA200000198A1 (ru) | 2-ациламинопропанамины в качестве антагонистов рецепторов тахикининов | |
EA200401137A1 (ru) | Фармацевтическая композиция, содержащая ингибитор pde4 или pde3/4 и антагонист гистаминового рецептора | |
HUP0402081A2 (hu) | NK-2 antagonista hatású egyenes láncú bázisos vegyületek és ezeket tartalmazó gyógyszerészeti készítmények | |
ATE384066T1 (de) | Thieno-pyrrole verbindungen als antagonisten der gonadotropin-freisetzenden hormonrezeptoren | |
ATE420860T1 (de) | N-substituierte amide als nk1 rezeptor antagonisten | |
DK0758312T3 (da) | Substituerede fusionerede og broforbundne bicykliske forbindelser som terapeutiske midler | |
DE60114597D1 (de) | Naphthamid-neurokinin antagonisten zur verwendung als medikamente | |
DE69828522D1 (de) | Antithrombotische mittel | |
DE60110233D1 (de) | Neue n-(2-phenyl-3-aminopropyl)naphtamide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |